Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Fibrosis × Simvastatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Fibrosis 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 sofosbuvir-velpatasvir drug combination 1 navitoclax 1 hepatitis B hyperimmune globulin 1 adefovir dipivoxil 1 Sorafenib 1 Simvastatin 1 Lamivudine 1 High-Energy Shock Waves 1 Erlotinib Hydrochloride 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02968810 2026-03-18

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting

52 enrolled 15 charts

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡